Redmile Group’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Hold |
|
|||||
|
2025
Q1 | $666K | Hold |
|
|||||
|
2024
Q4 | $801K | Hold |
|
|||||
|
2024
Q3 | $1.54M | Hold |
|
|||||
|
2024
Q2 | $1.38M | Hold |
|
|||||
|
2024
Q1 | $1.44M | Hold |
|
|||||
|
2023
Q4 | $1.3M | Hold |
|
|||||
|
2023
Q3 | $4.1M | Hold |
|
|||||
|
2023
Q2 | $6.49M | Hold |
|
|||||
|
2023
Q1 | $7.52M | Hold |
|
|||||
|
2022
Q4 | $9.79M | Hold |
|
|||||
|
2022
Q3 | $15.1M | Buy |
|
|||||
|
2022
Q2 | $3.21M | Hold |
|
|||||
|
2022
Q1 | $5.56M | Hold |
|
|||||
|
2021
Q4 | $10.7M | Sell |
|
|||||
|
2021
Q3 | $21M | Sell |
|
|||||
|
2021
Q2 | $31.3M | Sell |
|
|||||
|
2021
Q1 | $45.5M | Sell |
|
|||||
|
2020
Q4 | $89.4M | Sell |
|
|||||
|
2020
Q3 | $64.2M | Buy |
|